Obstetrics & Gynecology, Gynecologic Oncology · Germantown, TN
NPI
1720017577
Since 2006
Specialty
Obstetrics & Gynecology, Gynecologic Oncology
Code 207VX0201X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
7945 Wolf River Boulevard
Germantown, TN, 38138
Phone (901) 683-0055
Groups this clinician bills Medicare through
Medicare paid, 2024
$245K
5,302 services
Medicare patients, 2024
372
Average age 72
Drug cost, 2024
$795K
821 prescriptions
Company payments, 2025
$27K
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Todd D Tillmanns was code 36415 (venipuncture blood collection), 313 times for 91 patients. In total Todd D Tillmanns billed 5,302 services in 122 codes, and Medicare paid $245K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-07-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 313 | 91 | $8.65 | $2,707 |
| 99215 Office E&M - Established | Office | 312 | 166 | $122.20 | $38K |
| 85025 Blood Count | Office | 230 | 66 | $7.61 | $1,750 |
| 80048 Clinical Chemistry | Office | 197 | 56 | $8.29 | $1,633 |
| 80076 Clinical Chemistry | Office | 152 | 45 | $8.01 | $1,218 |
| 99214 Office E&M - Established | Office | 133 | 83 | $90.94 | $12K |
| 82565 Clinical Chemistry | Office | 96 | 68 | $4.98 | $478 |
| 86304 Immunoassay | Office | 74 | 30 | $20.39 | $1,509 |
| 99205 Office E&M - New | Office | 65 | 65 | $141.57 | $9,202 |
| 99233 Hospital E&M - Subsequent | Facility | 64 | 33 | $90.77 | $5,809 |
| 83735 Clinical Chemistry | Office | 59 | 17 | $6.57 | $388 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 51 | 12 | $68.60 | $3,499 |
| 58571 Other Organ Systems | Facility | 50 | 50 | $681.87 | $34K |
| 81003 Clinical Chemistry | Office | 44 | 20 | $2.20 | $96.8 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 43 | 29 | $11.73 | $504 |
By year: 2022 $1.9M for 104,754 services; 2023 $2.4M for 112,992 services; 2024 $245K for 5,302 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 313 | 91 | $8.65 | $2,707 |
| 85025 Blood Count | 230 | 66 | $7.61 | $1,750 |
| 80048 Clinical Chemistry | 197 | 56 | $8.29 | $1,633 |
| 80076 Clinical Chemistry | 152 | 45 | $8.01 | $1,218 |
| 82565 Clinical Chemistry | 96 | 68 | $4.98 | $478 |
| 86304 Immunoassay | 74 | 30 | $20.39 | $1,509 |
| 83735 Clinical Chemistry | 59 | 17 | $6.57 | $388 |
| 81003 Clinical Chemistry | 44 | 20 | $2.20 | $96.8 |
| 84443 Clinical Chemistry | 34 | 11 | $16.46 | $560 |
| 85610 Clinical Chemistry | 32 | 28 | $4.20 | $134 |
Medicare prescription drug claims, 2024
In 2024, the drug Todd D Tillmanns prescribed most often to Medicare patients was Ondansetron Odt (Ondansetron), with 91 prescriptions and refills. In total Todd D Tillmanns wrote 821 Medicare prescriptions that cost $795K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Odt Ondansetron | 91 | 91 | 85 | $601 |
| Oxycodone Hcl Generic | 74 | 74 | 74 | $202 |
| Letrozole Generic | 64 | 138 | 20 | $1,258 |
| Dexamethasone Generic | 32 | 32 | 23 | $682 |
| Eliquis Apixaban | 32 | 43 | 11 | $21K |
| Duloxetine Hcl Generic | 28 | 57 | Under 11 | $580 |
| Clobetasol Emollient Clobetasol Propionate/Emoll | 28 | 32 | 13 | $1,762 |
| Meloxicam Generic | 22 | 34 | Under 11 | $64.08 |
| Estradiol Generic | 22 | 26 | Under 11 | $917 |
| Megestrol Acetate Generic | 22 | 36 | 13 | $800 |
| Ondansetron Hcl Generic | 21 | 21 | 15 | $134 |
| Clobetasol Propionate Generic | 19 | 21 | 13 | $607 |
| Olanzapine Generic | 18 | 19 | 16 | $177 |
| Imiquimod Generic | 16 | 25 | Under 11 | $330 |
| Potassium Chloride Generic | 16 | 27 | Under 11 | $188 |
Brand drugs: - claims; generic drugs: 671 claims; opioid claims: 79.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Todd D Tillmanns $27K ($27K in general payments such as food, travel and fees) from 17 companies. The largest payer was GlaxoSmithKline, LLC. with $18K.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 17 | $18K |
| AstraZeneca Pharmaceuticals LP AZN | 5 | $3,462 |
| Abbvie Inc. ABBV | 3 | $2,513 |
| Intuitive Surgical, Inc. ISRG | 4 | $2,219 |
| Eisai Inc. 4523.T | 6 | $317 |
| Pfizer Inc. PFE | 2 | $158 |
| Gilead Sciences, Inc. GILD | 1 | $27.55 |
| Verastem, Inc. VSTM | 1 | $26.78 |
| Regeneron Healthcare Solutions, Inc. REGN | 1 | $22.47 |
| Dilon Technologies, Inc. | 1 | $22.3 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.